NITISINONE DIPHARMA 5 mg, hard capsule 60 capsules, CIP 3400930227282
Active ingredients: Nitisinone
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule60 capsules, CIP 3400930227282orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NITISINONE DIPHARMA 5 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquettes OPA : polyamide orienté aluminium PVC-Aluminium prédécoupées unitaires de 60 gélules
- Marketing authorisation holder
- DIPHARMA ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Oct 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62524376CIP73022728CIP133400930227282Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NITISINONEgélule | 5 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.